Cardiac Imaging: Page 112

Postmortem MRI shows sudden cardiac death invisible at autopsy
By Eric Barnes
In results that add substantial forensic power to identifying the cause of death, postmortem cardiac 3-tesla MRI has been found to identify sudden cardiac death in cases that are invisible at conventional autopsy, according to new research published online in the Journal of the American College of Cardiology.
April 16, 2013
2013 04 16 14 22 01 684 Jackowski peracute 20130416213647
Ziehm, Mallinckrodt strike a deal
By AuntMinnie.com staff writers
C-arm developer Ziehm Imaging and contrast developer Mallinckrodt have announced a collaboration in which the firms are more closely integrating their products in the field of vascular surgery.
April 14, 2013
Boston Scientific places new MRI pacing system
By AuntMinnie.com staff writers
Interventional technology developer Boston Scientific announced it has implanted its ImageReady MR-conditional pacing system in the first patient enrolled in the ImageReady MR Conditional Pacing System Clinical Study at Ohio Health's Riverside Methodist Hospital in Columbus.
April 14, 2013
Advanced CT reconstruction improves cardiac plaque assessment
By Eric Barnes
Automated plaque assessment in coronary CT angiography is a promising new way to evaluate a patient's plaque burden quickly and noninvasively -- but it won't be quick or accurate without the use of advanced iterative reconstruction, according to researchers from Massachusetts General Hospital in Boston.
April 11, 2013
2013 04 11 16 25 51 400 2013 04 12 Puchner Thumb
Cell>Point touts cardiac imaging agent trial results
By AuntMinnie.com staff writers
Radiopharmaceutical developer Cell>Point said that results from phase I and IIa studies of its technetium-99m-labeled ethylenedicysteine-glucosamine (99mTc-EC-G) nuclear imaging contrast agent have been favorable for evaluating the presence and severity of coronary artery disease.
April 9, 2013
ASE addresses TEE as part of Choosing Wisely
By AuntMinnie.com staff writers
The American Society of Echocardiography (ASE) has released a list of five interventions, including transesophageal echocardiography (TEE), that physicians and patients should discuss as part of the Choosing Wisely initiative.
April 3, 2013
Asia-Pacific interventional market primed for growth
By AuntMinnie.com staff writers
Spurred on by a steadily aging population and a high incidence of cardiovascular and cerebrovascular disease, the Asia-Pacific interventional radiology and cardiology market is projected to increase at a compound annual growth rate of 3.5% through 2017, said market research firm Frost & Sullivan.
March 27, 2013
Stereotaxis brings Niobe to Japan
By AuntMinnie.com staff writers
Image-guided interventional surgery firm Stereotaxis has received clearance for its Niobe magnetic navigation system from Japan's Pharmaceuticals and Medical Devices Agency.
March 24, 2013
CORE 320 study evaluates CCTA and SPECT for CAD diagnosis
By James Brice
A new comparative effectiveness study has found that 320-detector-row coronary CT angiography (CCTA) is better than SPECT myocardial perfusion imaging (MPI) for diagnosing coronary artery disease (CAD). But MPI still helps avoid unnecessary cardiac catheterization and revascularization.
March 24, 2013
FDA clears new use for GE's AdreView SPECT tracer
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration has approved a new cardiac indication for the AdreView (iobenguane I-123 injection) SPECT radiopharmaceutical from GE Healthcare.
March 21, 2013
Automated postprocessing tools improve cardiac MR scans
By Erik L. Ridley
Several image postprocessing methods are up for the task of assessing myocardial scar tissue from late gadolinium enhancement on cardiac MR exams, according to a multicenter study presented at the recent Society for Cardiovascular Magnetic Resonance meeting.
March 20, 2013
2013 03 20 14 15 33 881 Scar 400 20130320211800
Study affirms CCTA's value to rule out myocardial infarction
By James Brice
Coronary CT angiography (CCTA) is clinically safe and may use medical resources more effectively than conventional methods for evaluating chest pain in patients who are at low or intermediate risk of myocardial infarction, according to research presented earlier this month at the American College of Cardiology meeting.
March 18, 2013
Previous Page
Page 112 of 325
Next Page